VIRMA and cancer: High expression of KIAA1429 was significantly associated with poorer prognosis in patients with nine cancer types including ACC, BLCA, BRCA, ESCA, LGG, LIHC, PAAD, THCA, and UCEC (p < 0.05), reflecting its strong prognostic potential (Supporting Information: Figure S2A–I).